Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 3/20 | 0.59 |
| ▸ | NPC1 | O15118 | 6/20 | 0.53 |
| ▸ | RAB9A | P51151 | 6/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 5/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.51 |
| ▸ | USP2 | O75604 | 1/20 | 0.51 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.51 |
| ▸ | THRB | P10828 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.44 |
| ▸ | TP53 | P04637 | 1/20 | 0.44 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | CCKBR | P32239 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8947941 | 0.92 | TACR1 (0.71) | TACR1NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL8947995 | 0.90 | TACR1 (0.56) | TACR1NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL8948063 | 0.85 | TACR1 (0.48) | TACR1SMN1; SMN2TP53 | |
| Hydrochloric Acid SCHEMBL8948118 | 0.84 | TACR1 (0.50) | TACR1MAPT | |
| SCHEMBL8948077 | 0.80 | DPP4 (0.55) | TACR1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL8947979 | 0.79 | DPP4 (0.54) | TACR1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL8947972 | 0.79 | DPP4 (0.54) | TACR1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL8947829 | 0.78 | DPP4 (0.53) | TACR1NPC1RAB9ASMN1; SMN2MEN1 | |
| SCHEMBL8947984 | 0.78 | DPP4 (0.53) | TACR1NPC1RAB9AMEN1KMT2A | |
| SCHEMBL8947951 | 0.78 | DPP4 (0.61) | TACR1NPC1RAB9AMEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1999007413-A1 | SUBSTANCE P INHIBITORS IN COMBINATION WITH NMDA-BLOCKERS FOR TREATING PAIN | ALGOS PHARMACEUTICAL CORPORATION (US) | 1999-02-18 | — | — | WO | claimed |
| WO-1999007413-A1 | SUBSTANCE P INHIBITORS IN COMBINATION WITH NMDA-BLOCKERS FOR TREATING PAIN | ALGOS PHARMACEUTICAL CORPORATION (US) | 1999-02-18 | — | — | WO | disclosed |
| US-5527811-A | CALCIUM- AND SUBSTANCE P RECEPTOR-ANTAGONIST ACTIVITY | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 1996-06-18 | — | — | US | disclosed |
| EP-0634402-A1 | Isochinolinone derivatives, their production and use | Takeda Chemical Industries, Ltd. (JP) | 1995-01-18 | — | — | EP | disclosed |